Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07529938) titled 'Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy' on April 8.
Study Type: Observational
Primary Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital
Condition:
Hypertrophic Cardiomyopathy (HCM)
Obstructive Hypertrophic Cardiomyopathy (oHCM)
Intervention:
Drug: mavacamten
Recruitment Status: Not recruiting
Date of First Enrollment: January 1, 2024
Target Sample Size: 222
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07529938
Disclaimer: Curated by HT Syndication....